Salem, V
Inject at bedtime
Testing began 1 week after the sciatic nerve repair surgery was conducted and occurred at weekly intervals
Additionally, telisotuzumab vedotin (Teliso-V, ABBvie, North Chicago, Illinois, USA), formerly ABBV-399, a novel, first-in-class antibodydrug conjugate of ABT-700 and monomethyl auristatin E, showed promising safety and efficacy results in patients with c - MET -positive NSCLC, both as single-agent and in combination with erlotinib [106, 107], and is currently under study in combination with nivolumab as second line-treatment of advanced c-MET overexpressing NSCLC (NCT03539536)
Vitamin B12 Form: Methylcobalamin Supplement Type: Chewable tablet Dosage: 5,000 mcg Count: 60 tablets Certifications and Safety Standards: cGMP compliant
E) Figure E: tap syringe Step 9